D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Total Liabilities & Equity
myr1.4B
CAGR 3-Years
5%
CAGR 5-Years
8%
CAGR 10-Years
20%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Total Liabilities & Equity
myr115.1m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
11%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Total Liabilities & Equity
myr1.1B
CAGR 3-Years
20%
CAGR 5-Years
14%
CAGR 10-Years
13%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Total Liabilities & Equity
myr229.2m
CAGR 3-Years
7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Total Liabilities & Equity
myr543.5m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
6%
K
Kotra Industries Bhd
KLSE:KOTRA
Total Liabilities & Equity
myr344.1m
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
3%
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Total Liabilities & Equity?
Total Liabilities & Equity
1.4B MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Total Liabilities & Equity amounts to 1.4B MYR.

What is Duopharma Biotech Bhd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
20%

Over the last year, the Total Liabilities & Equity growth was -2%. The average annual Total Liabilities & Equity growth rates for Duopharma Biotech Bhd have been 5% over the past three years , 8% over the past five years , and 20% over the past ten years .

Back to Top